Recombinant Human TRIM5 delta protein (His tag)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human TRIM5 delta protein (His tag) is a Human Fragment protein, in the 1 to 248 aa range, expressed in HEK 293 cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, HPLC.
View Alternative Names
RNF88, TRIM5, Tripartite motif-containing protein 5, RING finger protein 88, RING-type E3 ubiquitin transferase TRIM5
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRIM5 delta participates in the innate immune defense mechanism against retroviral infections. Although the delta isoform lacks the PRYSPRY domain it still contributes to the restriction of retroviruses through an alternative mechanism involving protein oligomerization. TRIM5 delta does not form a part of large macromolecular complexes like full-length TRIM5 proteins do. Its unique structure enables distinct interactions which may impact its antiviral function independently or synergistically with other forms of TRIM5.
Pathways
Several innate immunity and antiviral defense pathways include functions of TRIM5 delta. An important pathway involves the disruption of the viral capsid after uncoating. TRIM5 delta associates with proteins such as TRIMCyp with the shared goal of impeding viral replication. The specific signaling cascade remains under exploration though it is evident TRIM5 delta modulates critical steps of the host's antiviral response contrasting other isoforms.
Specifications
Form
Liquid
Additional notes
The purity of ab196078 is greater than 95% as determined by SEC-HPLC and reducing SDS-PAGE.
General info
Function
Capsid-specific restriction factor that prevents infection from non-host-adapted retroviruses. Blocks viral replication early in the life cycle, after viral entry but before reverse transcription. In addition to acting as a capsid-specific restriction factor, also acts as a pattern recognition receptor that activates innate immune signaling in response to the retroviral capsid lattice. Binding to the viral capsid triggers its E3 ubiquitin ligase activity, and in concert with the heterodimeric ubiquitin conjugating enzyme complex UBE2V1-UBE2N (also known as UBC13-UEV1A complex) generates 'Lys-63'-linked polyubiquitin chains, which in turn are catalysts in the autophosphorylation of the MAP3K7/TAK1 complex (includes TAK1, TAB2, and TAB3). Activation of the MAP3K7/TAK1 complex by autophosphorylation results in the induction and expression of NF-kappa-B and MAPK-responsive inflammatory genes, thereby leading to an innate immune response in the infected cell. Restricts infection by N-tropic murine leukemia virus (N-MLV), equine infectious anemia virus (EIAV), simian immunodeficiency virus of macaques (SIVmac), feline immunodeficiency virus (FIV), and bovine immunodeficiency virus (BIV) (PubMed : 17156811). Plays a role in regulating autophagy through activation of autophagy regulator BECN1 by causing its dissociation from its inhibitors BCL2 and TAB2 (PubMed : 25127057). Also plays a role in autophagy by acting as a selective autophagy receptor which recognizes and targets HIV-1 capsid protein p24 for autophagic destruction (PubMed : 25127057).
Sequence similarities
Belongs to the TRIM/RBCC family.
Post-translational modifications
Degraded in a proteasome-independent fashion in the absence of viral infection but in a proteasome-dependent fashion following exposure to restriction sensitive virus.. Autoubiquitinated in a RING finger- and UBE2D2-dependent manner. Monoubiquitinated by TRIM21. Deubiquitinated by Yersinia YopJ. Ubiquitination may not lead to proteasomal degradation.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com